Bottom line
How much do BBH and IBB overlap?
66% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 85.8% of BBH's assets and 57.7% of IBB's. They share a meaningful core but differ in the rest of the portfolio.
IBB holds far more positions (254 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and IBB have in common
| Holding | % of BBH | % of IBB | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 7.50% | 7.50% |
| Gilead Sciences Inc | 12.79% | 7.52% | 7.52% |
| Vertex Pharmaceuticals Inc | 9.10% | 7.66% | 7.66% |
| Regeneron Pharmaceuticals Inc | 6.21% | 5.70% | 5.70% |
| Argenx SE | 4.97% | 3.15% | 3.15% |
| Natera Inc | 4.92% | 2.11% | 2.11% |
| IQVIA Holdings Inc | 4.31% | 3.18% | 3.18% |
| Alnylam Pharmaceuticals Inc | 3.83% | 5.68% | 3.83% |
| Biogen Inc | 3.63% | 2.03% | 2.03% |
| Moderna Inc | 3.36% | 0.88% | 0.88% |
| Illumina Inc | 3.17% | 1.41% | 1.41% |
| United Therapeutics Corp | 2.83% | 1.82% | 1.82% |
| BeOne Medicines Ltd | 2.81% | 2.11% | 2.11% |
| Insmed Inc | 2.67% | 2.95% | 2.67% |
| Incyte Corp | 2.49% | 1.62% | 1.62% |
| Neurocrine Biosciences Inc | 2.08% | 1.34% | 1.34% |
| BioMarin Pharmaceutical Inc | 1.34% | 1.02% | 1.02% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Revolution Medicines Inc — 5.27%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- Charles River Laboratories International Inc — 1.50%
- Qiagen Nv — 1.06%
- Tempus AI Inc — 0.98%
- State Street Global Advisors — 0.06%
Only in IBB
- BlackRock Funds III — 13.18%
- Mettler-Toledo International, Inc. — 2.49%
- Waters Corp. — 1.77%
- Genmab A/S — 1.38%
- Medpace Holdings, Inc. — 1.16%
- Exelixis, Inc. — 1.07%
- Ionis Pharmaceuticals, Inc. — 1.03%
- Madrigal Pharmaceuticals, Inc. — 0.92%
Asset mix
| Asset type | BBH | IBB |
|---|---|---|
| Stocks | 100.0% | 99.8% |
| Cash & short-term funds | 0.1% | 13.4% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)
Country mix
| Country | BBH | IBB |
|---|---|---|
| US | 87.3% | 98.6% |
| NL | 6.0% | 4.3% |
| CH | 2.8% | 2.7% |
| DK | — | 2.2% |
| DE | 1.9% | 0.7% |
| IE | 1.9% | 0.5% |
| GB | — | 1.0% |
| KY | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)
Check another pair
FAQ
How much do BBH and IBB overlap?
What stocks do BBH and IBB have in common?
Should I own both BBH and IBB?
Which holds more stocks, BBH or IBB?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.